Search
for
Sort by
Research 661–690 of 1000+
- Long‐term safety and efficacy of ritlecitinib in adults and adolescents with alopecia areata and at least 25% scalp hair loss: Results from the ALLEGRO‐LT phase 3, open‐label study
- Baricitinib in pediatric chronic immune thrombocytopenia and associated autoimmune conditions: a case report
- Abrocitinib Improved Dupilumab-Resistant Severe Atopic Dermatitis with Comorbid Mild Alopecia Areata in a 12-Year-Old Boy: A Case Report with 1-Year Follow-Up
- Patterns of clinical response in patients with alopecia areata treated with ritlecitinib in the ALLEGRO clinical development programme
- Melanoma: Genetic Abnormalities, Tumor Progression, Clonal Evolution and Tumor Initiating Cells
- dsRNA Released by Tissue Damage Activates TLR3 to Drive Skin Regeneration
- Conventional and novel stem cell based therapies for androgenic alopecia
- Immunopathology and Immunotherapy of Inflammatory Skin Diseases
- Single-cell analysis of temporal immune cell dynamics in alopecia areata reveals a causal role for clonally expanded CD8+ T cells in disease
- Role of the SOX family in cancer immune evasion: Emerging player and promising therapeutic opportunities
- Optimization of photobiomodulation therapy for spinal cord injury: A review
- Focused Review on Metal Nanoparticles in Hair Regeneration and Alopecia: Insights into Mechanisms, Assessment Techniques, Toxicity, Regulatory and Intellectual Property Perspectives
- Alopecia Areata – Effects of Treatment with Upadacitinib – Two Case Reports
- Evaluation of the level of serum Interleukins (IL-2, IL-4, IL-15 andIL-17) and its relationship with disease severity in patients with alopecia areata
- Selective Expansion of Tregs Using the IL-2 Cytokine Antibody Complex Does Not Reverse Established Alopecia Areata in C3H/HeJ Mice
- Human hair regeneration using organoids and hair-on-chip technologies
- Alopecia Areata Is Associated with an Increased Risk for Prediabetes and Obesity: A Nationwide Case—Control Study
- Microneedling combined with compound betamethasone in treatment of severe alopecia areata: A case report
- Ex Vivo Treatment with Allogenic Mesenchymal Stem Cells of a Healthy Donor on Peripheral Blood Mononuclear Cells of Patients with Severe Alopecia Areata: Targeting Dysregulated T Cells and the Acquisition of Immunotolerance
- Drug Armamentarium for alopecia areata
- Effective treatment of refractory alopecia areata in pediatric patients with oral abrocitinib
- A rare manifestation of STING-associated vasculopathy with onset in infancy: a case report
- Unmet Medical Needs in Chronic, Non-communicable Inflammatory Skin Diseases
- Hair Growth Effect of DN106212 in C57BL/6 Mouse and Its Network Pharmacological Mechanism of Action
- Frontiers in alopecia areata pathobiology research
- Autophagy: Guardian of Skin Barrier
- Recent Insights in Multi‐Target Drugs in Pharmacology and Medicinal Chemistry
- Perifolliculitis capitis abscedens et suffodiens treatment with tumor necrosis factor inhibitors and baricitinib: A case report and literature review
- Delivery Strategies of siRNA Therapeutics for Hair Loss Therapy
- Combination of Transcriptomics and Proteomics Reveals Differentially Expressed Genes and Proteins in the Skin of EDAR Gene-Targeted and Wildtype Cashmere Goats